Despite claiming a staggering 17.9 million lives globally in 2019, cardiovascular disease is often a silent and preventable threat that connects us all.
Key Takeaways
- In 2019, cardiovascular diseases (CVDs) caused 17.9 million deaths worldwide, equivalent to 32% of all global deaths
- Globally, 38% of premature deaths due to CVDs occur before the age of 70
- Of the 17.9 million CVD deaths in 2019, 85% were due to heart attack and stroke
- Global DALYs from CVD reached 520 million in 2019
- Nearly 523 million people worldwide were living with CVD in 2019
- Heart failure prevalence is 1-2% in general adult population, rising to 10% over age 70
- In women, 44% of CVD burden is attributable to behavioral risks
- Smoking causes 1.74 million CVD deaths yearly worldwide
- High body-mass index led to 5 million CVD deaths in 2019
- Statins reduce CVD events by 25% per 1 mmol/L LDL reduction
- Aspirin reduces CVD mortality by 23% in secondary prevention
- Blood pressure lowering reduces stroke risk by 35-40%
- Global CVD economic cost is $1 trillion yearly in health and productivity loss
- US spends $363 billion annually on CVD care
- Heart disease costs US $219 billion yearly including lost productivity
Cardiovascular disease is still the top cause of death and long-term disability worldwide, driving major health and economic pressures in 2026.
Economic
1Global CVD economic cost is $1 trillion yearly in health and productivity loss
Verified2US spends $363 billion annually on CVD care
Verified3Heart disease costs US $219 billion yearly including lost productivity
Verified4Stroke costs US $56 billion in direct medical costs 2020
Directional5In EU, CVD costs €210 billion yearly, 51% healthcare
Single source6China CVD costs $128 billion in 2019
Verified7India faces $2.5 trillion cumulative CVD cost 2010-2050
Verified8Low/middle-income countries lose $3.7 trillion GDP to CVD 2011-2025
Verified9UK CVD costs £19 billion yearly to economy
Directional10Australia spends $14.2 billion on CVD in 2020-21
Single source11Brazil CVD healthcare cost $5.7 billion yearly
Verified12Canada CVD costs $22 billion annually
Verified13South Africa loses 1.5% GDP to CVD
Verified14Global productivity loss from CVD is $470 billion yearly
Directional15US Medicare spends 25% of budget on CVD
Single sourceEconomic Interpretation
The planet's cardiovascular system is hemorrhaging money, with a global trillion-dollar band-aid barely stemming the flow from productivity and healthcare budgets alike.
Mortality
1In 2019, cardiovascular diseases (CVDs) caused 17.9 million deaths worldwide, equivalent to 32% of all global deaths
Verified2Globally, 38% of premature deaths due to CVDs occur before the age of 70
Verified3Of the 17.9 million CVD deaths in 2019, 85% were due to heart attack and stroke
Verified4Over three-quarters of CVD deaths take place in low- and middle-income countries
Directional5In 2019, 160 million people were living with heart failure globally
Single source6Age-standardized CVD mortality rate declined by 28.2% globally from 2000 to 2019
Verified7In 2019, ischemic heart disease caused 8.9 million deaths worldwide
Verified8Stroke accounted for 6.6 million deaths globally in 2019
Verified9CVD death rates are 1.5 times higher in rural areas than urban areas in the US
Directional10In the US, heart disease is the leading cause of death, killing nearly 700,000 people in 2021
Single source11Stroke kills about 160,000 Americans annually
Verified12Black Americans have the highest death rate from heart disease at 211.6 per 100,000
Verified13In Europe, CVD causes over 4 million deaths yearly, representing 45% of all deaths
Verified14Age-standardized mortality rate from CVD in EU was 172.3 per 100,000 in 2019
Directional15In low-income countries, 37.5% of CVD deaths occur under age 70
Single source16High systolic blood pressure accounted for 10.8 million CVD deaths in 2019
Verified17In 2020, COVID-19 increased CVD mortality by 10-15% in high-income countries
Verified18Global CVD mortality projected to rise to 23.6 million by 2030
Verified19In India, CVD causes 2.8 million deaths annually, 25% of all deaths
Directional20China sees 4.5 million CVD deaths per year
Single source21In sub-Saharan Africa, rheumatic heart disease mortality is 0.15 million yearly
Verified22US men have a CVD mortality rate of 179.8 per 100,000 vs 126.1 for women
Verified23In the UK, CVD mortality fell 76% from 1979 to 2019
Verified24Australia reports 47,000 CVD deaths in 2020
Directional25Japan has the lowest CVD mortality at 110 per 100,000
Single source26Russia has high CVD mortality at 500 per 100,000
Verified27In Brazil, CVD causes 400,000 deaths yearly
Verified28Canada sees 55,000 CVD deaths annually
Verified29In South Africa, CVD mortality rate is 250 per 100,000
DirectionalMortality Interpretation
While the global battle against heart disease has seen impressive victories, the sobering reality is that it remains a brutally efficient killer, disproportionately claiming lives in the prime of adulthood and in the world's most vulnerable communities.
Prevalence
1Global DALYs from CVD reached 520 million in 2019
Verified2Nearly 523 million people worldwide were living with CVD in 2019
Verified3Heart failure prevalence is 1-2% in general adult population, rising to 10% over age 70
Verified4Atrial fibrillation prevalence is 2-3% in people over 65
Directional5Globally, hypertension affects 1.28 billion adults aged 30-79
Single source6In the US, 127.9 million adults have CVD
Verified7About 48% of US adults have some form of CVD
Verified8Coronary heart disease affects 20.1 million US adults
Verified9Heart failure prevalence in US is 6.7 million people age 20+
Directional10Stroke prevalence in US adults is 3%, or 7.4 million people
Single source11In Europe, 49 million people live with CVD
Verified12Hypertension prevalence in EU is 30-45% of adults
Verified13In China, 330 million people have CVD
Verified14India has 75 million hypertension cases
Directional15In low-income countries, CVD prevalence is rising 2% annually
Single source16Australia has 1.2 million with coronary heart disease
Verified17UK prevalence of CVD is 7.6% in adults
Verified18In Brazil, 35 million adults have hypertension
Verified19Canada reports 2.6 million with heart disease
Directional20South Africa has 7.5 million hypertensives
Single source21Japan has 15 million CVD patients
Verified22Russia sees 20 million with hypertension
Verified23In sub-Saharan Africa, 100 million have hypertension
Verified24Global atrial fibrillation cases numbered 59 million in 2019
Directional25US peripheral artery disease affects 8.5 million adults
Single sourcePrevalence Interpretation
The staggering global march of cardiovascular disease, a relentless pandemic of preventable suffering, paints a picture of 520 million years of healthy life lost and nearly every nation counting its casualties in the millions.
Risk Factors
1In women, 44% of CVD burden is attributable to behavioral risks
Verified2Smoking causes 1.74 million CVD deaths yearly worldwide
Verified3High body-mass index led to 5 million CVD deaths in 2019
Verified4Ambient particulate matter pollution causes 1.1 million CVD deaths annually
Directional5Hypertension is the leading modifiable risk factor, causing 29% of CVD deaths
Single source6Diabetes prevalence increases CVD risk by 2-4 fold
Verified7In US, 47% of adults have high blood pressure
Verified8Obesity affects 42% of US adults, doubling CVD risk
Verified9Smoking is responsible for 20% of CVD deaths in US
Directional10Physical inactivity contributes to 6% of global CVD burden
Single source11High LDL cholesterol raises CVD risk by 25-30%
Verified12In Europe, 26% of adults smoke, major CVD risk
Verified13Air pollution PM2.5 increases CVD risk by 10-20%
Verified14Poor diet causes 11 million CVD deaths yearly
Directional15Family history doubles CVD risk if first-degree relative affected before 60
Single source16Chronic kidney disease triples CVD risk
Verified17In women, oral contraceptives increase stroke risk 2-fold if hypertensive
Verified18HIV infection raises CVD risk by 50-100%
Verified19Socioeconomic disadvantage increases CVD risk by 40%
Directional20Shift work elevates CVD risk by 40%
Single source21High sodium intake causes 1.89 million CVD deaths yearly
Verified22Low fruit intake responsible for 2.5 million CVD deaths
Verified23In US Blacks, hypertension prevalence is 56% vs 48% Whites
Verified24Alcohol consumption >14 drinks/week raises CVD risk 20%
Directional25Depression increases CVD risk by 30-50%
Single sourceRisk Factors Interpretation
It is a grim irony that our hearts are being defeated by a largely self-inflicted pandemic of stubbornly widespread killers we already know how to stop.
Treatment
1Statins reduce CVD events by 25% per 1 mmol/L LDL reduction
Verified2Aspirin reduces CVD mortality by 23% in secondary prevention
Verified3Blood pressure lowering reduces stroke risk by 35-40%
Verified4SGLT2 inhibitors reduce heart failure hospitalization by 30%
Directional5Cardiac rehab reduces CVD mortality by 20-30%
Single source6In US, 90% of eligible get statins for secondary prevention
Verified7ICD implantation reduces sudden death by 30% in high-risk patients
Verified8PCI success rate for STEMI is 95%, reducing mortality to 5%
Verified9CABG improves survival by 20% over PCI in multivessel disease
Directional10Anticoagulation for AF reduces stroke by 64%
Single source11Lifestyle intervention reduces CVD events by 30% in diabetes
Verified12GLP-1 agonists cut major CVD events by 12-26%
Verified13Smoking cessation reduces CVD risk by 50% within 1 year
Verified14Mediterranean diet lowers CVD recurrence by 30%
Directional15In Europe, BP control rates are 40% in hypertensives
Single source16Beta-blockers post-MI reduce mortality by 23%
Verified17TAVR success rate is 95% for aortic stenosis
Verified18Renal denervation lowers BP by 10 mmHg in resistant HTN
Verified19Exercise training improves ejection fraction by 3-4% in HF
Directional20DOACs have 50% lower intracranial bleed risk vs warfarin
Single source21Colchicine reduces CVD events by 31% post-ACS
VerifiedTreatment Interpretation
It's a pharmacological and lifestyle armada, firing a salvo of 20-35% relative risk reductions, yet still utterly dependent on us to actually deploy these remarkably effective tools to conquer the stubbornly human problems of access, adherence, and inertia.
Sources & References
- Reference 1WHOwho.intVisit source
- Reference 2THELANCETthelancet.comVisit source
- Reference 3NCBIncbi.nlm.nih.govVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5HEARTheart.orgVisit source
- Reference 6ECec.europa.euVisit source
- Reference 7AHAJOURNALSahajournals.orgVisit source
- Reference 8NATUREnature.comVisit source
- Reference 9BHFbhf.org.ukVisit source
- Reference 10AIHWaihw.gov.auVisit source
- Reference 11HEARTANDSTROKEheartandstroke.caVisit source
- Reference 12ESCARDIOescardio.orgVisit source
- Reference 13SAMRCsamrc.ac.zaVisit source
- Reference 14J-CIRCj-circ.or.jpVisit source
- Reference 15HEALTHDATAhealthdata.orgVisit source
- Reference 16BMJbmj.comVisit source
- Reference 17KIDNEYkidney.orgVisit source
- Reference 18NEJMnejm.orgVisit source
- Reference 19HEALTHAFFAIRShealthaffairs.orgVisit source